• Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
  

PubMed=9436977; DOI=10.1101/gad.12.2.163; PMCID=PMC316442
Thomas R. Yeager, Sandy DeVries, David F. Jarrard, Ching-Hai Kao, Stephen Y. Nakada, Timothy D. Moon, Reginald Bruskewitz, Walter M. Stadler, Lorraine Faxon Meisner, Kennedy W. Gilchrist, Michael Abbott Newton ...Show all 13 authors... , Frederic M. Waldman, Catherine Armstrong Reznikoff; Show fewer authors
Overcoming cellular senescence in human cancer pathogenesis.
Genes Dev. 12:163-174(1998)

PubMed=10919661
Somdatta Sarkar, Knut P. Julicher, Melissa S. Burger, Veronique Della Valle, Christian-Jacques Larsen, Thomas R. Yeager, Timothy Bruce Grossman, Robert W. Nickells, Chris Protzel, David F. Jarrard, Catherine Armstrong Reznikoff;
Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
Cancer Res. 60:3862-3871(2000)

PubMed=24367658; DOI=10.1371/journal.pone.0084411; PMCID=PMC3867501
Rebecca L. Ross, Julie E. Burns, Claire F. Taylor, Paul Mellor, Deborah H. Anderson, Margaret A. Knowles;
Identification of mutations in distinct regions of p85 alpha in urothelial cancer.
PLoS ONE 8:e84411.1-e84411.11(2013)

PubMed=24035680; DOI=10.1016/j.eururo.2013.08.057
Carolyn D. Hurst, Fiona M. Platt, Margaret A. Knowles;
Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine.
Eur. Urol. 65:367-369(2014)

PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350
Tahlita C.M. Zuiverloon, Florus C. de Jong, James C. Costello, Dan Theodorescu;
Systematic review: characteristics and preclinical uses of bladder cancer cell lines.
Bladder Cancer 4:169-183(2018)